Scinai Immunotherapeutics Ltd. held its Annual Meeting on December 22, 2025, where shareholders approved several proposals including the re-election of Mr. Mark Germain, amendments to increase authorized shares, and grants of options to executives. A total of 2,498,440,000 shares were represented, with significant votes in favor of each proposal, indicating strong support from shareholders.